Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Decreased rate of surgical site infection after spinal surgery with instrumentation using bundled approach including surveillance and intrawound vancomycin application.

Sono T, Fujibayashi S, Izeki M, Shimizu Y, Masamoto K, Morizane K, Otsuki B, Tanida S, Nagao M, Ichiyama S, Matsuda S.

Medicine (Baltimore). 2018 Aug;97(34):e12010. doi: 10.1097/MD.0000000000012010.

2.

Combination Therapy With Intensive Granulocyte and Monocyte Adsorptive Apheresis Plus Ustekinumab in Patients With Refractory Crohn's Disease.

Tanida S, Mizoshita T, Ozeki K, Katano T, Tanaka M, Nishie H, Shimura T, Okamoto Y, Kubota E, Kataoka H, Joh T.

Ther Apher Dial. 2018 Jun;22(3):295-300. doi: 10.1111/1744-9987.12697. Epub 2018 May 23.

PMID:
29790276
3.

Refractory gastric antral ulcers without Helicobacter pylori infection and non-steroidal anti-inflammatory drugs.

Nishie H, Kataoka H, Kato H, Suzuki T, Ichikawa H, Nojiri Y, Kitagawa M, Inagaki Y, Iwasaki H, Tanaka M, Katano T, Okamoto Y, Ozeki K, Mizoshita T, Shimura T, Kubota E, Tanida S, Joh T.

Clin J Gastroenterol. 2018 Jun;11(3):251-256. doi: 10.1007/s12328-018-0835-7. Epub 2018 Feb 16.

PMID:
29453508
4.

Sagittal imbalance treated with L5 pedicle subtraction osteotomy with short lumbar fusion from L4 to sacrum using four screws into L4 for enhanced fixation two additional vertebral screws: a technical note.

Wangdi K, Otsuki B, Fujibayashi S, Tanida S, Masamoto K, Matsuda S.

Eur Spine J. 2018 Feb 7. doi: 10.1007/s00586-018-5487-2. [Epub ahead of print]

PMID:
29417322
5.

Excellent antitumor effects for gastrointestinal cancers using photodynamic therapy with a novel glucose conjugated chlorin e6.

Nishie H, Kataoka H, Yano S, Yamaguchi H, Nomoto A, Tanaka M, Kato A, Shimura T, Mizoshita T, Kubota E, Tanida S, Joh T.

Biochem Biophys Res Commun. 2018 Feb 19;496(4):1204-1209. doi: 10.1016/j.bbrc.2018.01.171. Epub 2018 Jan 31.

PMID:
29408755
6.

Factors influencing spinal sagittal balance, bone mineral density, and Oswestry Disability Index outcome measures in patients with rheumatoid arthritis.

Masamoto K, Otsuki B, Fujibayashi S, Shima K, Ito H, Furu M, Hashimoto M, Tanaka M, Lyman S, Yoshitomi H, Tanida S, Mimori T, Matsuda S.

Eur Spine J. 2018 Feb;27(2):406-415. doi: 10.1007/s00586-017-5401-3. Epub 2017 Nov 28.

PMID:
29185111
7.

Ankle-foot orthosis using elastomer-embedded flexible joint.

Abe I, Ishiya K, Oshimoto T, Kikuchi T, Tanida S, Yasuda T.

Conf Proc IEEE Eng Med Biol Soc. 2017 Jul;2017:4499-4502. doi: 10.1109/EMBC.2017.8037856.

PMID:
29060897
8.

Influence of spinopelvic alignment and morphology on deviation in the course of the psoas major muscle.

Tanida S, Fujibayashi S, Otsuki B, Masamoto K, Matsuda S.

J Orthop Sci. 2017 Nov;22(6):1001-1008. doi: 10.1016/j.jos.2017.08.002. Epub 2017 Aug 24.

PMID:
28843447
9.

Novel ankle orthosis with elastomer-embedded flexible joint.

Kikuchi T, Ishiya K, Abe I, Tanida S, Yasuda T.

IEEE Int Conf Rehabil Robot. 2017 Jul;2017:1124-1129. doi: 10.1109/ICORR.2017.8009400.

PMID:
28813972
10.

Prospective comparison of preference and efficacy of adalimumab and infliximab for treating ulcerative colitis naive to antitumor necrosis factor therapy.

Mizoshita T, Katano T, Tanida S, Hirano A, Miyaki T, Ozeki K, Suzuki Y, Sugimura N, Kataoka H, Joh T.

Medicine (Baltimore). 2017 Aug;96(32):e7800. doi: 10.1097/MD.0000000000007800.

11.

Expression and subcellular localization of AT motif binding factor 1 in colon tumours.

Kataoka H, Miura Y, Kawaguchi M, Suzuki S, Okamoto Y, Ozeki K, Shimura T, Mizoshita T, Kubota E, Tanida S, Takahashi S, Asai K, Joh T.

Mol Med Rep. 2017 Sep;16(3):3095-3102. doi: 10.3892/mmr.2017.7016. Epub 2017 Jul 15.

12.

Green Synthesis of (R)-Terbutaline for Recyclable Catalytic Asymmetric Transfer Hydrogenation in Ionic Liquids.

Uchimoto H, Ikeda M, Tanida S, Ohhashi K, Chihara Y, Shigeta T, Arimitsu K, Yamashita M, Nishide K, Kawasaki I.

Chem Pharm Bull (Tokyo). 2017;65(4):389-395. doi: 10.1248/cpb.c16-00949.

13.

A multicenter randomized trial comparing rabeprazole and itopride in patients with functional dyspepsia in Japan: the NAGOYA study.

Kamiya T, Shikano M, Kubota E, Mizoshita T, Wada T, Tanida S, Kataoka H, Adachi H, Hirako M, Okuda N, Joh T.

J Clin Biochem Nutr. 2017 Mar;60(2):130-135. doi: 10.3164/jcbn.16-106. Epub 2017 Feb 24.

14.

Adalimumab therapy in a patient with Crohn's disease with a giant pelvic paraganglioma after chemotherapy.

Mizoshita T, Ando M, Sagawa H, Mori Y, Katano T, Ozeki K, Tanida S, Okamoto Y, Shimura T, Kubota E, Kataoka H, Kamiya T, Joh T.

Clin J Gastroenterol. 2017 Jun;10(3):250-254. doi: 10.1007/s12328-017-0726-3. Epub 2017 Mar 7.

PMID:
28271435
15.

Preoperative assessment of the ureter with dual-phase contrast-enhanced computed tomography for lateral lumbar interbody fusion procedures.

Fujibayashi S, Otsuki B, Kimura H, Tanida S, Masamoto K, Matsuda S.

J Orthop Sci. 2017 May;22(3):420-424. doi: 10.1016/j.jos.2017.01.009. Epub 2017 Feb 12.

PMID:
28202301
16.

Bovine lactoferrin and Crohn's disease: a case study.

Alexander DB, Iigo M, Abdelgied M, Ozeki K, Tanida S, Joh T, Takahashi S, Tsuda H.

Biochem Cell Biol. 2017 Feb;95(1):133-141. doi: 10.1139/bcb-2016-0107. Epub 2016 Nov 30.

PMID:
28165294
17.

Ectopic Gastric and Intestinal Phenotypes, Neuroendocrine Cell Differentiation, and SOX2 Expression Correlated With Early Tumor Progression in Colorectal Laterally Spreading Tumors.

Katano T, Mizoshita T, Tsukamoto H, Nishie H, Inagaki Y, Hayashi N, Nomura S, Ozeki K, Okamoto Y, Shimura T, Mori Y, Kubota E, Tanida S, Kataoka H, Kuno T, Takahashi S, Joh T.

Clin Colorectal Cancer. 2017 Jun;16(2):141-146. doi: 10.1016/j.clcc.2016.09.009. Epub 2016 Oct 6.

PMID:
27816419
18.

Anticancer Effects of a New Aminosugar-conjugated Platinum Complex Agent Against Cisplatin-resistant Gastric Cancer.

Hayashi N, Kataoka H, Yano S, Kikuchi JI, Tanaka M, Nishie H, Kinoshita Y, Hatano M, Nomoto A, Ogawa A, Inoue M, Mizoshita T, Shimura T, Mori Y, Kubota E, Tanida S, Joh T.

Anticancer Res. 2016 Nov;36(11):6005-6009.

PMID:
27793927
19.

Vertebral Endplate Cyst as a Predictor of Nonunion After Lumbar Interbody Fusion: Comparison of Titanium and Polyetheretherketone Cages.

Tanida S, Fujibayashi S, Otsuki B, Masamoto K, Takahashi Y, Nakayama T, Matsuda S.

Spine (Phila Pa 1976). 2016 Oct 15;41(20):E1216-E1222.

PMID:
27054449
20.

Persistent reflux symptoms cause anxiety, depression, and mental health and sleep disorders in gastroesophageal reflux disease patients.

Kimura Y, Kamiya T, Senoo K, Tsuchida K, Hirano A, Kojima H, Yamashita H, Yamakawa Y, Nishigaki N, Ozeki T, Endo M, Nakanishi K, Sando M, Inagaki Y, Shikano M, Mizoshita T, Kubota E, Tanida S, Kataoka H, Katsumi K, Joh T.

J Clin Biochem Nutr. 2016 Jul;59(1):71-7. doi: 10.3164/jcbn.16-9. Epub 2016 May 21.

21.

Long-Term Clinical Remission in Biologically Naïve Crohn's Disease Patients with Adalimumab Therapy, Including Analyses of Switch from Adalimumab to Infliximab.

Mizoshita T, Tanida S, Ozeki K, Katano T, Shimura T, Mori Y, Kubota E, Kataoka H, Kamiya T, Joh T.

Case Rep Gastroenterol. 2016 Jun 14;10(2):283-91. doi: 10.1159/000445105. eCollection 2016 May-Aug.

22.

Organizing Pneumonia in a Patient with Quiescent Crohn's Disease.

Tanida S, Takemura M, Mizoshita T, Ozeki K, Katano T, Shimura T, Mori Y, Kubota E, Kataoka H, Kamiya T, Joh T.

Case Rep Gastrointest Med. 2016;2016:8129864. doi: 10.1155/2016/8129864. Epub 2016 Jun 20.

23.

Immunogenic cell death due to a new photodynamic therapy (PDT) with glycoconjugated chlorin (G-chlorin).

Tanaka M, Kataoka H, Yano S, Sawada T, Akashi H, Inoue M, Suzuki S, Inagaki Y, Hayashi N, Nishie H, Shimura T, Mizoshita T, Mori Y, Kubota E, Tanida S, Takahashi S, Joh T.

Oncotarget. 2016 Jul 26;7(30):47242-47251. doi: 10.18632/oncotarget.9725.

24.

Characterizing the dissolution profiles of supersaturable salts, cocrystals, and solvates to enhance in vivo oral absorption.

Hisada N, Takano R, Takata N, Shiraki K, Ueto T, Tanida S, Kataoka M, Yamashita S.

Eur J Pharm Biopharm. 2016 Jun;103:192-199. doi: 10.1016/j.ejpb.2016.04.004. Epub 2016 Apr 7.

PMID:
27060622
25.

Long-Term Efficacy of Adalimumab in Patients With Intestinal Behcet's Disease: Eight Consecutive Cases.

Tanida S, Mizoshita T, Nishie H, Ozeki K, Katano T, Shimura T, Kubota E, Kataoka H, Kamiya T, Joh T.

J Clin Med Res. 2016 Apr;8(4):334-7. doi: 10.14740/jocmr2477w. Epub 2016 Feb 27.

26.

Evaluation of the Micellization Mechanism of an Amphipathic Graft Copolymer with Enhanced Solubility of Ipriflavone.

Tanida S, Kurokawa T, Sato H, Kadota K, Tozuka Y.

Chem Pharm Bull (Tokyo). 2016;64(1):68-72. doi: 10.1248/cpb.c15-00655.

27.

An open-label prospective randomized multicenter study of intensive versus weekly granulocyte and monocyte apheresis in active crohn's disease.

Yoshimura N, Yokoyama Y, Matsuoka K, Takahashi H, Iwakiri R, Yamamoto T, Nakagawa T, Fukuchi T, Motoya S, Kunisaki R, Kato S, Hirai F, Ishiguro Y, Tanida S, Hiraoka S, Mitsuyama K, Ishihara S, Tanaka S, Otaka M, Osada T, Kagaya T, Suzuki Y, Nakase H, Hanai H, Watanabe K, Kashiwagi N, Hibi T.

BMC Gastroenterol. 2015 Nov 19;15:163. doi: 10.1186/s12876-015-0390-3.

28.

Combination Therapy With Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Refractory Ulcerative Colitis.

Tanida S, Mizoshita T, Nishie H, Ozeki K, Katano T, Kubota E, Kataoka H, Kamiya T, Joh T.

J Clin Med Res. 2015 Nov;7(11):884-9. doi: 10.14740/jocmr2333w. Epub 2015 Sep 25.

29.

Advances in refractory ulcerative colitis treatment: A new therapeutic target, Annexin A2.

Tanida S, Mizoshita T, Ozeki K, Katano T, Kataoka H, Kamiya T, Joh T.

World J Gastroenterol. 2015 Aug 7;21(29):8776-86. doi: 10.3748/wjg.v21.i29.8776. Review.

30.

Adalimumab treatment in intestinal Behçet's disease: Relationship with ectopic mucin 5AC glycoprotein expression and endoscopic improvement.

Mizoshita T, Tanida S, Joh T.

Dig Liver Dis. 2015 Nov;47(11):991-2. doi: 10.1016/j.dld.2015.07.007. Epub 2015 Jul 17. No abstract available.

PMID:
26250949
31.

Managing refractory Crohn's disease: challenges and solutions.

Tanida S, Ozeki K, Mizoshita T, Tsukamoto H, Katano T, Kataoka H, Kamiya T, Joh T.

Clin Exp Gastroenterol. 2015 Apr 10;8:131-40. doi: 10.2147/CEG.S61868. eCollection 2015. Review.

32.

Preventive effect of rebamipide on N-methyl-N'-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats.

Tsukamoto H, Mizoshita T, Katano T, Hayashi N, Ozeki K, Ebi M, Shimura T, Mori Y, Tanida S, Kataoka H, Tsukamoto T, Tatematsu M, Joh T.

Exp Toxicol Pathol. 2015 Mar;67(3):271-7. doi: 10.1016/j.etp.2015.01.003. Epub 2015 Jan 20.

PMID:
25617151
33.

Gastric mesenchymal myofibroblasts maintain stem cell activity and proliferation of murine gastric epithelium in vitro.

Katano T, Ootani A, Mizoshita T, Tanida S, Tsukamoto H, Ozeki K, Kataoka H, Joh T.

Am J Pathol. 2015 Mar;185(3):798-807. doi: 10.1016/j.ajpath.2014.11.007. Epub 2014 Dec 26.

PMID:
25546442
34.

A novel photodynamic therapy targeting cancer cells and tumor-associated macrophages.

Hayashi N, Kataoka H, Yano S, Tanaka M, Moriwaki K, Akashi H, Suzuki S, Mori Y, Kubota E, Tanida S, Takahashi S, Joh T.

Mol Cancer Ther. 2015 Feb;14(2):452-60. doi: 10.1158/1535-7163.MCT-14-0348. Epub 2014 Dec 15.

35.

Oncolytic reovirus combined with trastuzumab enhances antitumor efficacy through TRAIL signaling in human HER2-positive gastric cancer cells.

Hamano S, Mori Y, Aoyama M, Kataoka H, Tanaka M, Ebi M, Kubota E, Mizoshita T, Tanida S, Johnston RN, Asai K, Joh T.

Cancer Lett. 2015 Jan 28;356(2 Pt B):846-54. doi: 10.1016/j.canlet.2014.10.046. Epub 2014 Nov 17.

PMID:
25444894
36.

The first case of biological therapy discontinuation after a complete remission induced by maintenance therapy with adalimumab for refractory ulcerative colitis.

Tanida S, Mizoshita T, Ozeki K, Tsukamoto H, Mori Y, Kubota E, Kataoka H, Kamiya T, Joh T.

J Clin Med Res. 2015 Feb;7(2):118-21. doi: 10.14740/jocmr1991w. Epub 2014 Nov 19.

37.

MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells.

Mori Y, Akita K, Tanida S, Ishida A, Toda M, Inoue M, Yashiro M, Sawada T, Hirakawa K, Nakada H.

J Biol Chem. 2014 Dec 19;289(51):35193-204. doi: 10.1074/jbc.M114.586461. Epub 2014 Nov 4.

38.

Adalimumab for the treatment of Japanese patients with intestinal Behçet's disease.

Tanida S, Inoue N, Kobayashi K, Naganuma M, Hirai F, Iizuka B, Watanabe K, Mitsuyama K, Inoue T, Ishigatsubo Y, Suzuki Y, Nagahori M, Motoya S, Nakamura S, Arora V, Robinson AM, Thakkar RB, Hibi T.

Clin Gastroenterol Hepatol. 2015 May;13(5):940-8.e3. doi: 10.1016/j.cgh.2014.08.042. Epub 2014 Sep 19.

39.

Therapeutic effects of biobran, modified arabinoxylan rice bran, in improving symptoms of diarrhea predominant or mixed type irritable bowel syndrome: a pilot, randomized controlled study.

Kamiya T, Shikano M, Tanaka M, Ozeki K, Ebi M, Katano T, Hamano S, Nishiwaki H, Tsukamoto H, Mizoshita T, Mori Y, Kubota E, Tanida S, Kataoka H, Okuda N, Joh T.

Evid Based Complement Alternat Med. 2014;2014:828137. doi: 10.1155/2014/828137. Epub 2014 Aug 5.

40.

Negative regulation of Toll-like receptor-4 signaling through the binding of glycosylphosphatidylinositol-anchored glycoprotein, CD14, with the sialic acid-binding lectin, CD33.

Ishida A, Akita K, Mori Y, Tanida S, Toda M, Inoue M, Nakada H.

J Biol Chem. 2014 Sep 5;289(36):25341-50. doi: 10.1074/jbc.M113.523480. Epub 2014 Jul 24.

41.

Adalimumab Treatment in Biologically Naïve Crohn's Disease: Relationship with Ectopic MUC5AC Expression and Endoscopic Improvement.

Mizoshita T, Tanida S, Tsukamoto H, Ozeki K, Katano T, Nishiwaki H, Ebi M, Mori Y, Kubota E, Kataoka H, Kamiya T, Joh T.

Gastroenterol Res Pract. 2014;2014:687257. doi: 10.1155/2014/687257. Epub 2014 Apr 16.

42.

Management of systolic blood pressure after endoscopic submucosal dissection is crucial for prevention of post-ESD gastric bleeding.

Ebi M, Shimura T, Nishiwaki H, Tanaka M, Tsukamoto H, Ozeki K, Sawada T, Mizoshita T, Mori Y, Kubota E, Tanida S, Kataoka H, Joh T.

Eur J Gastroenterol Hepatol. 2014 May;26(5):504-9. doi: 10.1097/MEG.0000000000000072.

PMID:
24589830
43.

Galectin-3 binds to MUC1-N-terminal domain and triggers recruitment of β-catenin in MUC1-expressing mouse 3T3 cells.

Tanida S, Mori Y, Ishida A, Akita K, Nakada H.

Biochim Biophys Acta. 2014 Jun;1840(6):1790-7. doi: 10.1016/j.bbagen.2014.02.008. Epub 2014 Feb 18.

PMID:
24561267
44.

Antitumor effects in gastrointestinal stromal tumors using photodynamic therapy with a novel glucose-conjugated chlorin.

Tanaka M, Kataoka H, Yano S, Ohi H, Moriwaki K, Akashi H, Taguchi T, Hayashi N, Hamano S, Mori Y, Kubota E, Tanida S, Joh T.

Mol Cancer Ther. 2014 Apr;13(4):767-75. doi: 10.1158/1535-7163.MCT-13-0393. Epub 2014 Feb 19.

45.

CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion.

Akita K, Tanaka M, Tanida S, Mori Y, Toda M, Nakada H.

Eur J Cell Biol. 2013 Aug-Sep;92(8-9):257-63. doi: 10.1016/j.ejcb.2013.10.005. Epub 2013 Oct 26.

PMID:
24246580
46.

Development of control model for intelligently controllable ankle-foot orthosis.

Kikuchi T, Tanida S, Yasuda T, Fujikawa T.

Conf Proc IEEE Eng Med Biol Soc. 2013;2013:330-3. doi: 10.1109/EMBC.2013.6609504.

PMID:
24109691
47.

Binding of the sialic acid-binding lectin, Siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth.

Tanida S, Akita K, Ishida A, Mori Y, Toda M, Inoue M, Ohta M, Yashiro M, Sawada T, Hirakawa K, Nakada H.

J Biol Chem. 2013 Nov 1;288(44):31842-52. doi: 10.1074/jbc.M113.471318. Epub 2013 Sep 17.

48.

Diagnostic utility of small-caliber and conventional endoscopes for gastric cancer and analysis of endoscopic false-negative gastric cancers.

Kataoka H, Mizuno K, Hayashi N, Tanaka M, Nishiwaki H, Ebi M, Mizoshita T, Mori Y, Kubota E, Tanida S, Kamiya T, Joh T.

World J Gastrointest Endosc. 2013 Sep 16;5(9):440-5. doi: 10.4253/wjge.v5.i9.440.

49.

Annexin A2 regulates a disintegrin and metalloproteinase 17-mediated ectodomain shedding of pro-tumor necrosis factor-α in monocytes and colon epithelial cells.

Tsukamoto H, Tanida S, Ozeki K, Ebi M, Mizoshita T, Shimura T, Mori Y, Kataoka H, Kamiya T, Fukuda S, Higashiyama S, Joh T.

Inflamm Bowel Dis. 2013 Jun;19(7):1365-73. doi: 10.1097/MIB.0b013e318281f43a.

PMID:
23702712
50.

Colon Mucosa Exhibits Loss of Ectopic MUC5AC Expression in Patients with Ulcerative Colitis Treated with Oral Tacrolimus.

Mizoshita T, Tanida S, Tsukamoto H, Ozeki K, Katano T, Ebi M, Mori Y, Kataoka H, Kamiya T, Joh T.

ISRN Gastroenterol. 2013 Apr 9;2013:304894. doi: 10.1155/2013/304894. Print 2013.

Supplemental Content

Loading ...
Support Center